|
Executive Summit: Emerging Strategic and Financial
Issues
in the Pharmaceutical Industry
November 16, 2010
Yale Club, New York City
12:00 PM – 5:00 PM
Luncheon and Summit Co-Sponsored By:
Selected Topics and Speakers
The Future of Biopharma:
Where Business Meets Policy
William Looney, Editor-In-Chief, Pharmaceutical Executive
The
Current and Future State of the Pharmaceutical Industry
Peter Young, President, Young & Partners
The Pharmaceutical Market:
Trends and Forecasts
Doug Long, Vice President, IMS
Health Inc.
Pharma Venture
Investing: Lessons and Observations
Barbara Dalton, Vice President Venture Capital, Pfizer Inc.
Pharma M&A:
Driving Factors in the Market
Peter Young, President, Young & Partners
Cutting
Edge Patent Issues Affecting Pharma/Biotech
Randolph Guggenheimer III, Managing Director, Young & Partners (Speaker
and Moderator)
Adam Golden, Partner, Kaye Scholer
LLP
Stephen Simes,
President and CEO, BioSante
Pharmaceuticals
Dr. Gregory Wiederrecht,
Vice President & Head, External Scientific Affairs, Worldwide
Licensing, Merck
By
invitation only. This event is for pharma
and biotech company senior executives. To apply for an invitation,
please email your name, title, company affiliation and contact
information to Jason Lacerna
or call him at 212-682-5555. If you qualify, you will be invited to
attend as guests of the co-sponsors. There will be no charge for the
lunch or the summit.
» Apply for an Invitation
Young &
Partners is an international investment
banking firm focused on providing M&A and financing services to
the pharmaceutical, biotech, medical device and diagnostic and
chemical industries.
Pharmaceutical Executive is the leading
magazine serving the needs of pharmaceutical executives. |
